Depo-Subq Provera 104 en es it fr

Depo-Subq Provera 104 Brand names, Depo-Subq Provera 104 Analogs

Depo-Subq Provera 104 Brand Names Mixture

  • Lunelle (Medroxyprogesterone + Estradiol)

Depo-Subq Provera 104 Chemical_Formula

C22H32O3

Depo-Subq Provera 104 RX_link

http://www.rxlist.com/cgi/generic/medrox.htm

Depo-Subq Provera 104 fda sheet

Depo-Subq_Provera_104 FDA

Depo-Subq Provera 104 msds (material safety sheet)

Depo-Subq Provera 104 Synthesis Reference

P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)

Depo-Subq Provera 104 Molecular Weight

344.488 g/mol

Depo-Subq Provera 104 Melting Point

220 - 223.5 oC

Depo-Subq Provera 104 H2O Solubility

22.2mg/L

Depo-Subq Provera 104 State

Solid

Depo-Subq Provera 104 LogP

3.606

Depo-Subq Provera 104 Dosage Forms

Tablets; Depo injection

Depo-Subq Provera 104 Indication

Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.

Depo-Subq Provera 104 Pharmacology

Medroxyprogesterone is a synthetic progestin more potent than progesterone.

Depo-Subq Provera 104 Absorption

Rapidly absorbed from GI tract

Depo-Subq Provera 104 side effects and Toxicity

Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.

Depo-Subq Provera 104 Patient Information

Depo-Subq Provera 104 Organisms Affected

Humans and other mammals